Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD)
Copyright © 2015 Elsevier B.V. All rights reserved..
Alzheimer's disease (AD), the most common form of dementia among the elderly, is characterized by the progressive decline of cognitive function. Increasing evidence indicates that the production and accumulation of amyloid β (Aβ), particularly soluble Aβ oligomers, is central to the pathogenesis of AD. Our recent studies have demonstrated that nobiletin, a polymethoxylated flavone from citrus peels, ameliorates learning and memory impairment in olfactory-bulbectomized mice, amyloid precursor protein transgenic mice, NMDA receptor antagonist-treated mice, and senescence-accelerated mouse prone 8. Here, we present evidence that this natural compound improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of AD (3XTg-AD) that progressively develops amyloid plaques, neurofibrillary tangles, and cognitive impairments. Treatment with nobiletin (30 mg/kg) for 3 months reversed the impairment of short-term memory and recognition memory in 3XTg-AD mice. Our ELISA analysis also showed that nobiletin reduced the levels of soluble Aβ1-40 in the brain of 3XTg-AD mice. Furthermore, nobiletin reduced ROS levels in the hippocampus of 3XTg-AD as well as wild-type mice. These results suggest that this natural compound has potential to become a novel drug for the treatment and prevention of AD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:289 |
|---|---|
| Enthalten in: |
Behavioural brain research - 289(2015) vom: 01. Aug., Seite 69-77 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nakajima, Akira [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.02.2016 Date Revised 10.12.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bbr.2015.04.028 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM248437062 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM248437062 | ||
| 003 | DE-627 | ||
| 005 | 20231224151411.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbr.2015.04.028 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0828.xml |
| 035 | |a (DE-627)NLM248437062 | ||
| 035 | |a (NLM)25913833 | ||
| 035 | |a (PII)S0166-4328(15)00270-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nakajima, Akira |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD) |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.02.2016 | ||
| 500 | |a Date Revised 10.12.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2015 Elsevier B.V. All rights reserved. | ||
| 520 | |a Alzheimer's disease (AD), the most common form of dementia among the elderly, is characterized by the progressive decline of cognitive function. Increasing evidence indicates that the production and accumulation of amyloid β (Aβ), particularly soluble Aβ oligomers, is central to the pathogenesis of AD. Our recent studies have demonstrated that nobiletin, a polymethoxylated flavone from citrus peels, ameliorates learning and memory impairment in olfactory-bulbectomized mice, amyloid precursor protein transgenic mice, NMDA receptor antagonist-treated mice, and senescence-accelerated mouse prone 8. Here, we present evidence that this natural compound improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of AD (3XTg-AD) that progressively develops amyloid plaques, neurofibrillary tangles, and cognitive impairments. Treatment with nobiletin (30 mg/kg) for 3 months reversed the impairment of short-term memory and recognition memory in 3XTg-AD mice. Our ELISA analysis also showed that nobiletin reduced the levels of soluble Aβ1-40 in the brain of 3XTg-AD mice. Furthermore, nobiletin reduced ROS levels in the hippocampus of 3XTg-AD as well as wild-type mice. These results suggest that this natural compound has potential to become a novel drug for the treatment and prevention of AD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 3XTg-AD | |
| 650 | 4 | |a Alzheimer's disease | |
| 650 | 4 | |a Memory | |
| 650 | 4 | |a Nobiletin | |
| 650 | 4 | |a Oxidative stress | |
| 650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
| 650 | 7 | |a Flavones |2 NLM | |
| 650 | 7 | |a Peptide Fragments |2 NLM | |
| 650 | 7 | |a amyloid beta-protein (1-40) |2 NLM | |
| 650 | 7 | |a amyloid beta-protein (1-42) |2 NLM | |
| 650 | 7 | |a nobiletin |2 NLM | |
| 650 | 7 | |a D65ILJ7WLY |2 NLM | |
| 700 | 1 | |a Aoyama, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Shin, Eun-Joo |e verfasserin |4 aut | |
| 700 | 1 | |a Nam, Yunsung |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Hyoung-Chun |e verfasserin |4 aut | |
| 700 | 1 | |a Nagai, Taku |e verfasserin |4 aut | |
| 700 | 1 | |a Yokosuka, Akihito |e verfasserin |4 aut | |
| 700 | 1 | |a Mimaki, Yoshihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Yokoi, Tsuyoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ohizumi, Yasushi |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada, Kiyofumi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Behavioural brain research |d 1993 |g 289(2015) vom: 01. Aug., Seite 69-77 |w (DE-627)NLM012632252 |x 1872-7549 |7 nnns |
| 773 | 1 | 8 | |g volume:289 |g year:2015 |g day:01 |g month:08 |g pages:69-77 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbr.2015.04.028 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 289 |j 2015 |b 01 |c 08 |h 69-77 | ||